Industry-leading hemp and cannabinoid solutions provider GVB Biopharma unveils high-purity Cannabicitran (CBT) Isolate, broadening its suite of rare cannabinoid offerings. PRINEVILLE, Ore., March 13, 2025 /PRNewswire/ -- GVB Biopharma, a premier developer, manufacturer, and global...
Hence then, the article about gvb biopharma expands product portfolio with launch of premium cbt isolate was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( GVB Biopharma Expands Product Portfolio with Launch of Premium CBT Isolate )
Also on site :
- NANOscientific Symposium Series 2025 Concludes Successfully, Marked by a Landmark Celebration of 40 Years of AFM at Stanford
- Somalia: Somalia Parliament Approves $1.38 Billion Budget for 2026
- From Hypocritical Loyalty to Transparent Desire: XFun Addresses the Dating "Deception Crisis" as 50% of Users Now Normalize Infidelity